PT  - JOURNAL ARTICLE
AU  - T Chua
TI  - The evolving role of molecular imaging for coronary artery disease: where do we stand today?
AID  - 10.1136/ha.2008.000273
DP  - 2009 Jan 01
TA  - Heart Asia
PG  - 1--5
VI  - 1
IP  - 1
4099  - http://heartasia.bmj.com/content/1/1/1.short
4100  - http://heartasia.bmj.com/content/1/1/1.full
SO  - Heart Asia2009 Jan 01; 1
AB  - The landscape of cardiac imaging is changing rapidly. There are promising new developments in molecular imaging on the horizon. It is likely that nuclear cardiology will continue to play an important role in the evaluation of CAD, but that role must evolve to meet clinical needs, competing technologies and the increasing emphasis on ensuring that imaging adds value and improves outcomes. This review offers some suggestions on the optimal role nuclear imaging can play vis-à-vis alternative options such as CT, but more data are needed before definitive recommendations can be made. Randomised trials comparing different diagnostic strategies can and should be performed to strengthen the foundations of clinical practice in nuclear cardiology. An evidence-based approach to imaging is here to stay.